Drug Type Small molecule drug |
Synonyms 2,4-Diamino-5-[[5-(1H-pyrazol-5-yl)-2-thienyl]methyl]-1H-pyrimidin-6-one |
Target |
Action agonists |
Mechanism PAH agonists(Phenylalanine hydroxylase agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Phenylketonurias | Preclinical | United States | 27 Dec 2023 |





